{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:32:56Z","timestamp":1776483176224,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.phrs.2021.106034","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T02:30:08Z","timestamp":1639449008000},"page":"106034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Adenovirus vaccine therapy with CD137L promotes CD8+ DCs-mediated multifunctional CD8+ T cell immunity and elicits potent anti-tumor activity"],"prefix":"10.1016","volume":"175","author":[{"given":"Jiage","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengli","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junnian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.phrs.2021.106034_bib1","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohen","year":"2005","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.phrs.2021.106034_bib2","first-page":"17009","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev."},{"issue":"23","key":"10.1016\/j.phrs.2021.106034_bib3","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2217\/fon-2021-0256","article-title":"Preclinical activity of cobimetinib alone or in combination with chemotherapy and targeted therapies in renal cell carcinoma","volume":"17","author":"Zhang","year":"2021","journal-title":"Future. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2021.106034_bib4","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.4143\/crt.2015.316","article-title":"Systemic treatments for metastatic renal cell carcinoma: 10-year experience of immunotherapy and targeted therapy","volume":"48","author":"Kim","year":"2016","journal-title":"Cancer. Res. Treat."},{"issue":"6","key":"10.1016\/j.phrs.2021.106034_bib5","first-page":"507","article-title":"Treatment of renal cell carcinoma: current status and future directions","volume":"67","author":"Barata","year":"2017","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.phrs.2021.106034_bib6","first-page":"h988","article-title":"Cancer vaccines","volume":"350","author":"Butterfield","year":"2015","journal-title":"BMJ. Clin. Res. Ed."},{"issue":"6","key":"10.1016\/j.phrs.2021.106034_bib7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.eururo.2009.01.043","article-title":"Vaccine therapy in patients with renal cell carcinoma","volume":"55","author":"Van Poppel","year":"2009","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.phrs.2021.106034_bib8","doi-asserted-by":"crossref","DOI":"10.4110\/in.2021.21.e6","article-title":"Adenovirus vectors: excellent tools for vaccine development","volume":"21","author":"Chang","year":"2021","journal-title":"Immune. Netw."},{"issue":"3","key":"10.1016\/j.phrs.2021.106034_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1464-410X.2007.07006.x","article-title":"Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma","volume":"100","author":"Sandlund","year":"2007","journal-title":"BJU. Int."},{"issue":"2","key":"10.1016\/j.phrs.2021.106034_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1309\/AJCPVJDS28KNYZLD","article-title":"Immunohistochemical reevaluation of carbonic anhydrase IX (CA IX) expression in tumors and normal tissues","volume":"141","author":"Luong-Player","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"19","key":"10.1016\/j.phrs.2021.106034_bib11","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.3390\/ijms21197146","article-title":"Carbonic anhydrase IX in renal cell carcinoma, implications for disease management","volume":"21","author":"Courcier","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2021.106034_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/CJI.0000000000000336","article-title":"Dose-escalation, and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells transduced With AdGMCA9 (DC-AdGMCAIX) in patients with metastatic renal cell carcinoma","volume":"43","author":"Faiena","year":"2020","journal-title":"J. Immunother."},{"issue":"13","key":"10.1016\/j.phrs.2021.106034_bib13","first-page":"7454","article-title":"Effective inhibition of tumor in vivo with a novel DNA vaccine targeting chimeric G250","volume":"24","author":"Li","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2021.106034_bib14","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1111\/cas.15044","article-title":"Co-immunization with L-Myc enhances CD8(+) or CD103(+) DCs mediated tumor-specific multi-functional CD8(+) T cell responses","volume":"112","author":"Chai","year":"2021","journal-title":"Cancer. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2021.106034_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/1535-7163.MCT-18-0832","article-title":"Combining DNA vaccine and AIM2 in H1 nanoparticles exert anti-renal carcinoma effects via enhancing tumor- specific multi-functional CD8(+) T-cell responses","volume":"18","author":"Chai","year":"2019","journal-title":"Mol. Cancer. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2021.106034_bib16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<865::AID-IJC21>3.0.CO;2-Q","article-title":"Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250","volume":"85","author":"Grabmaier","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2021.106034_bib17","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.urology.2006.08.1073","article-title":"RENCA\/carbonic anhydrase-IX: a murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma","volume":"68","author":"Shvarts","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.phrs.2021.106034_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575967","article-title":"Mucosal CD8 T cell responses are shaped by Batf3-DC after foodborne listeria monocytogenes infection","volume":"11","author":"Imperato","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2021.106034_bib19","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3389\/fimmu.2019.02216","article-title":"CD137L-DCs, potent immune-stimulators-history, characteristics, and perspectives","volume":"10","author":"Zeng","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2021.106034_bib20","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.ymthe.2019.07.019","article-title":"Recombinant adenovirus expressing a soluble fusion protein PD-1\/CD137L subverts the suppression of CD8(+) T cells in HCC","volume":"27","author":"Zhang","year":"2019","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.phrs.2021.106034_bib21","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26859","article-title":"CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses","volume":"2","author":"Harfuddin","year":"2013","journal-title":"Oncoimmunology"},{"issue":"21","key":"10.1016\/j.phrs.2021.106034_bib22","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1158\/0008-5472.CAN-17-0610","article-title":"Anti-CD137 suppresses tumor growth by blocking reverse signaling by CD137 ligand","volume":"77","author":"Kang","year":"2017","journal-title":"Cancer. Res."},{"issue":"4","key":"10.1016\/j.phrs.2021.106034_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1113367","article-title":"CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses","volume":"5","author":"Dharmadhikari","year":"2015","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.phrs.2021.106034_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1067745","article-title":"Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination","volume":"5","author":"Wimmers","year":"2016","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.phrs.2021.106034_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/humc.2018.129","article-title":"Establishing China\u2019s National standard for the recombinant adenovirus type 5 vector-based ebola vaccine (Ad5-EBOV) virus titer","volume":"29","author":"Li","year":"2018","journal-title":"Hum. Gene. Ther. Clin. Dev."},{"issue":"3","key":"10.1016\/j.phrs.2021.106034_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002374","article-title":"Phase I study of a multitargeted recombinant Ad5 PSA\/MUC-1\/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)","volume":"9","author":"Bilusic","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2021.106034_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40425-019-0576-2","article-title":"Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients","volume":"7","author":"Snook","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.phrs.2021.106034_bib28","first-page":"751","article-title":"A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5 Delta 24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy","volume":"18","author":"Hakkarainen","year":"2006","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.phrs.2021.106034_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3380","article-title":"New function of a well-known promoter: enhancer activity of minimal CMV promoter enables efficient dual-cassette transgene expression","volume":"23","author":"Boateng-Antwi","year":"2021","journal-title":"J. Gene. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.106034_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2005.08.044","article-title":"Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of A beta 1-6: toward safer and effective vaccines against Alzheimer\u2019s disease","volume":"336","author":"Kim","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2021.106034_bib31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00262-015-1706-4","article-title":"Extended evaluation of a phase 1\/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer","volume":"64","author":"Balint","year":"2015","journal-title":"Cancer. Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.phrs.2021.106034_bib32","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00262-018-2144-x","article-title":"CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8(+) T cells to Tc1 phenotype","volume":"67","author":"Dharmadhikari","year":"2018","journal-title":"Cancer. Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.phrs.2021.106034_bib33","doi-asserted-by":"crossref","first-page":"21076","DOI":"10.1002\/jcp.28710","article-title":"Induction of CD137 expression by viral genes reduces T cell costimulation","volume":"234","author":"Wu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2021.106034_bib34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1189\/jlb.3A0213-079RRR","article-title":"Trogocytic CD137 transfer causes an internalization of CD137 ligand on murine APCs leading to reduced T cell costimulation","volume":"97","author":"Shao","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phrs.2021.106034_bib35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fimmu.2019.00868","article-title":"Increased Akt-driven glycolysis is the basis for the higher potency of CD137L-DCs","volume":"10","author":"Zeng","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2021.106034_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12935-020-01605-0","article-title":"CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8(+)T cells via NF-kappa B signaling","volume":"20","author":"Hu","year":"2020","journal-title":"Cancer. Cell. Int."},{"issue":"1","key":"10.1016\/j.phrs.2021.106034_bib37","doi-asserted-by":"crossref","first-page":"1860482","DOI":"10.1080\/2162402X.2020.1860482","article-title":"T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-gamma, TNF-alpha or IL-2 production","volume":"10","author":"van Asten","year":"2021","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.phrs.2021.106034_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001762","article-title":"Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist","volume":"9","author":"Upadhyaya","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2021.106034_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2020.11.041","article-title":"CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma","volume":"499","author":"Muth","year":"2021","journal-title":"Cancer. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2021.106034_bib40","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1038\/s41598-019-50365-z","article-title":"HCV p7 as a novel vaccine-target inducing multifunctional CD4(+) and CD8(+) T-cells targeting liver cells expressing the viral antigen","volume":"9","author":"Filskov","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.phrs.2021.106034_bib41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.20021804","article-title":"Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells","volume":"197","author":"Yu","year":"2003","journal-title":"J. Exp. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821006186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821006186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:35:14Z","timestamp":1760913314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821006186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"alternative-id":["S1043661821006186"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.106034","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus vaccine therapy with CD137L promotes CD8+ DCs-mediated multifunctional CD8+ T cell immunity and elicits potent anti-tumor activity","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.106034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106034"}}